Literature DB >> 10627599

Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain.

M C Senut1, S T Suhr, B Kaspar, F H Gage.   

Abstract

Expanded polyglutamine (polyQ) tracts have been linked to a new class of human disease characterized by psychiatric/motor syndromes associated with specific patterns of neurodegeneration. We have used a direct viral approach to locally express expanded polyglutamine tracts fused to the green fluorescent protein (97Q-GFP) in the adult rat brain. We show that intrastriatal expression of 97Q-GFP causes the rapid formation of fibrillar, cytoplasmic, and ubiquitinated nuclear aggregates in neurons. 97Q-GFP expression also results in a specific temporal pattern of cell death in the striatum. Co-infection studies suggest that high level 97Q-GFP-expressing cells die during the first month, whereas low level 97Q-GFP-expressing neurons persist for up to 6 months after infection. These data indicate that cumulative expression of polyQ repeats throughout the life of the animal is not required to induce neuronal death, but rather acute overexpression of polyQ is toxic to adult neurons in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10627599      PMCID: PMC6774116     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

1.  Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract.

Authors:  Y P Goldberg; D W Nicholson; D M Rasper; M A Kalchman; H B Koide; R K Graham; M Bromm; P Kazemi-Esfarjani; N A Thornberry; J P Vaillancourt; M R Hayden
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

2.  Selective sparing of a class of striatal neurons in Huntington's disease.

Authors:  R J Ferrante; N W Kowall; M F Beal; E P Richardson; E D Bird; J B Martin
Journal:  Science       Date:  1985-11-01       Impact factor: 47.728

Review 3.  The ubiquitin-proteasome proteolytic pathway.

Authors:  A Ciechanover
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

4.  Huntingtin localization in brains of normal and Huntington's disease patients.

Authors:  E Sapp; C Schwarz; K Chase; P G Bhide; A B Young; J Penney; J P Vonsattel; N Aronin; M DiFiglia
Journal:  Ann Neurol       Date:  1997-10       Impact factor: 10.422

5.  Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse.

Authors:  J M Ordway; S Tallaksen-Greene; C A Gutekunst; E M Bernstein; J A Cearley; H W Wiener; L S Dure; R Lindsey; S M Hersch; R S Jope; R L Albin; P J Detloff
Journal:  Cell       Date:  1997-12-12       Impact factor: 41.582

Review 6.  Gene transfer by adeno-associated virus vectors into the central nervous system.

Authors:  X Xiao; J Li; T J McCown; R J Samulski
Journal:  Exp Neurol       Date:  1997-03       Impact factor: 5.330

7.  Regulation of gene expression in vivo following transduction by two separate rAAV vectors.

Authors:  K G Rendahl; S E Leff; G R Otten; S K Spratt; D Bohl; M Van Roey; B A Donahue; L K Cohen; R J Mandel; O Danos; R O Snyder
Journal:  Nat Biotechnol       Date:  1998-08       Impact factor: 54.908

8.  SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

Authors:  E N Burright; H B Clark; A Servadio; T Matilla; R M Feddersen; W S Yunis; L A Duvick; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

9.  Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

Authors:  F Saudou; S Finkbeiner; D Devys; M E Greenberg
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

10.  In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes.

Authors:  M Dragunow; R L Faull; P Lawlor; E J Beilharz; K Singleton; E B Walker; E Mee
Journal:  Neuroreport       Date:  1995-05-09       Impact factor: 1.837

View more
  21 in total

Review 1.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

2.  Lentiviral vectors for the central nervous system.

Authors:  Elena Armandola
Journal:  MedGenMed       Date:  2004-09-24

Review 3.  Versatile somatic gene transfer for modeling neurodegenerative diseases.

Authors:  Ronald L Klein; David B Wang; Michael A King
Journal:  Neurotox Res       Date:  2009-08-11       Impact factor: 3.911

4.  BimEL as a possible molecular link between proteasome dysfunction and cell death induced by mutant huntingtin.

Authors:  Rebecca Leon; Nithya Bhagavatula; Onome Ulukpo; Mark McCollum; Jianning Wei
Journal:  Eur J Neurosci       Date:  2010-05-24       Impact factor: 3.386

Review 5.  Genetic strategies to study TDP-43 in rodents and to develop preclinical therapeutics for amyotrophic lateral sclerosis.

Authors:  David B Wang; Michael A Gitcho; Brian C Kraemer; Ronald L Klein
Journal:  Eur J Neurosci       Date:  2011-07-21       Impact factor: 3.386

6.  Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states.

Authors:  Ronald L Klein; Robert D Dayton; Jason B Tatom; Cynthia G Diaczynsky; Michael F Salvatore
Journal:  Eur J Neurosci       Date:  2008-04       Impact factor: 3.386

7.  AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease.

Authors:  Nicholas R Franich; Helen L Fitzsimons; Dahna M Fong; Matthias Klugmann; Matthew J During; Deborah Young
Journal:  Mol Ther       Date:  2008-03-25       Impact factor: 11.454

Review 8.  Prospects for the pharmacotherapy of amyotrophic lateral sclerosis : old strategies and new paradigms for the third millennium.

Authors:  Barry W Festoff; Zhiming Suo; Bruce A Citron
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

9.  Lead exposure disrupts global DNA methylation in human embryonic stem cells and alters their neuronal differentiation.

Authors:  Marie-Claude Senut; Arko Sen; Pablo Cingolani; Asra Shaik; Susan J Land; Douglas M Ruden
Journal:  Toxicol Sci       Date:  2014-02-11       Impact factor: 4.849

10.  The beta amyloid peptide can act as a modular aggregation domain.

Authors:  Christopher D Link; Virginia Fonte; Christine M Roberts; Brian Hiester; Michael A Silverman; Gretchen H Stein
Journal:  Neurobiol Dis       Date:  2008-08-22       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.